Geron Corporation (GERN) Stock Forecast
GERN analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.40 / 5 from 5 analysts
- Price target
- $4.25 average of analyst targets
- Upside to target
- +263.2% from the latest close
- Next earnings
- November 4, 2026 EPS estimate $-0.01
- 52-week range
- $1.07 – $1.95
GERN analyst ratings
5 analystsNumber of analysts at each rating.
GERN price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
GERN earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.01 | −$0.01 | −$0.01 | −$0.03 | +66.7% | 1 |
| Current fiscal year (2026) | −$0.02 | −$0.02 | −$0.02 | −$0.10 | +80.6% | 1 |
| Next fiscal year (2027) | $0.04 | $0.04 | $0.04 | −$0.02 | +300.0% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
GERN revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $60.7M | $57.2M | $62.7M | +28.5% | 5 |
| Current fiscal year (2026) | $236.3M | $233.1M | $240.2M | +28.5% | 5 |
| Next fiscal year (2027) | $342.0M | $319.8M | $413.3M | +44.7% | 5 |
GERN EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
GERN revenue: reported and forecast
GERN EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | −$0.01 | −$0.01 | −$0.01 | −$0.01 | −$0.01 | +100.0% | 0 up · 0 down |
| Current fiscal year (2026) | −$0.02 | −$0.02 | −$0.02 | −$0.02 | −$0.02 | 0.0% | 0 up · 0 down |
| Next fiscal year (2027) | $0.07 | $0.07 | $0.07 | $0.06 | $0.04 | −38.5% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
GERN earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; GERN beat in 11 of 12.
What analysts expect from GERN
5 analysts cover Geron; their consensus rating is buy (4.40 on a 1–5 scale, where 5 is a strong buy). The average price target is $4.25, 263.2% above the latest close of $1.17. Analysts expect earnings of −$0.02 per share for 2026, +80.6% from a year earlier. For 2027 the average estimate is $0.04 per share on revenue of $342.0 million. Geron beat the EPS estimate in 11 of the last 12 quarters.
Related: GERN income statement, GERN key metrics, GERN chart. See the GERN stock overview for the latest quote and news.
GERN forecast FAQ
What is Geron's price target?
The average analyst price target for Geron is $4.25, 263.2% above the latest close of $1.17.
Is Geron a buy, hold or sell?
Of 5 analysts covering Geron, 3 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Geron's EPS forecast?
Analysts forecast −$0.02 per share for 2026 (range −$0.02 to −$0.02); for 2027 the estimate is $0.04.
What is Geron's revenue forecast?
The average revenue estimate for 2026 is $236.3 million, growth of 28.5%; for 2027 it is $342.0 million.
When does Geron report earnings?
Geron is expected to report results for the quarter ending September 30, 2026 on November 4, 2026 before the market opens; the EPS estimate is $-0.01.
Does Geron usually beat earnings estimates?
Geron reported EPS at or above the analyst estimate in 11 of the last 12 quarters.